Freeman Capital Management · activist-deck
Freeman Capital Management | Activist Presentation Deck | 95 slides
95 pages · 3 arc beats · 2 loops
Freeman Capital Management | Activist Presentation Deck | 95 slides
Freeman Capital Management · 2023-05 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707580859095
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 89 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 8 slides 100% 8/8 slides 100% 8/8 slides · 43 hits — 0/8 slides
— 0/8 slides
50% 4/8 slides 100% 8/8 slides 100% 8/8 slides Agitate (Make it worse) 46 slides 100% 46/46 slides 100% 46/46 slides · 213 hits — 0/46 slides
15.2% 7/46 slides · 9 hits 60.9% 28/46 slides · 30 hits 100% 46/46 slides — 0/46 slides
Solution (Provide relief) 35 slides 100% 35/35 slides 100% 35/35 slides · 121 hits — 0/35 slides
11.4% 4/35 slides 28.6% 10/35 slides 100% 35/35 slides 25.7% 9/35 slides Slide inventory
95 every slide · same image gating as the playbook
06
The slide uses a clear 'problem-solution' structure typical of activist investor decks.summarize
07
The slide uses a timeline-annotated line chart to correlate management decisions with stock price decline.expose_contradiction
08
The table highlights the significant decline in stock value for all listed companies, with a specific column calculating the relative performance of peers compacompare_peers
11
Uses a 'problem-consequence-solution' narrative structure.diagnose_problem
12
Uses a two-column layout to contrast failures across two different drug programs.diagnose_problem
13
Uses a three-column layout to categorize grievances.diagnose_problem
14
Uses a bar chart to compare current spending vs proposed budget across five categories.diagnose_problem
15
The chart uses a line graph to illustrate the negative market reaction to corporate financing decisions.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
16
Uses a magnifying glass icon to symbolize scrutiny of the Board.name_villain
Open slide detailBeat · Agitate (Make it worse)
17
Uses urgency-based framing to justify activist intervention.diagnose_problem
Open slide detailBeat · Agitate (Make it worse)
18
The slide uses a list-based structure to justify the opposition to specific board members.introduce_nominees
Open slide detailBeat · Agitate (Make it worse)
20
The slide uses a chevron-based process flow to visualize the timeline.plan_implementation
Open slide detailBeat · Agitate (Make it worse)
21
The slide uses a badge icon to symbolize commitment.introduce_nominees
Open slide detailBeat · Agitate (Make it worse)
23
The table uses checkmarks to indicate the presence of specific skills or experiences for each individual.compare_peers
Open slide detailBeat · Agitate (Make it worse)
25
Uses red X icons to emphasize failure points.name_villain
Open slide detailBeat · Agitate (Make it worse)
27
Provides foundational definitions for clinical trial terminology used in the deck.establish_context
Open slide detailBeat · Agitate (Make it worse)
28
The slide uses a critical tone to frame the company's current clinical strategy as 'ill-conceived' and 'flawed'.name_villain
Open slide detailBeat · Agitate (Make it worse)
29
Two-column layout: left side has line illustration of clinical documents (vial, briefcase, paper); right side stacks claim label, FCM analysis, highlighted findexpose_contradiction
Open slide detailBeat · Agitate (Make it worse)
30
The chart uses a tree-like structure to show patient distribution across different clinical trial phases.analyze_data
Open slide detailBeat · Agitate (Make it worse)
31
The slide uses a timeline format to systematically undermine the credibility of the CEO by pointing out that his roles were not backfilled and questioning his cexpose_contradiction
Open slide detailBeat · Agitate (Make it worse)
33
Uses a list of 'False' labels to systematically debunk company statements.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
34
The slide focuses on criticizing the specific clinical trial strategy of the company's leadership (Barrow).diagnose_problem
Open slide detailBeat · Agitate (Make it worse)
35
Uses a narrative structure to dismantle management's enrollment projections.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
36
Uses a vertical timeline to visualize the repetition of a specific claim over time.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
37
Uses a timeline framework to show the progression of negligence.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
38
Uses a timeline framework to highlight the gap between management's claims and reality.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
40
The slide uses a question mark icon to frame the content as an inquiry or interrogation of management's actions.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
41
The slide uses a callout box to emphasize the contradiction between dropped trials and executive compensation/performance metrics.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
42
Uses a narrative structure to contrast past promises with current lack of results.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
44
The slide uses multiple pull-quotes to highlight negative analyst sentiment.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
45
The slide uses a visual metaphor of a declining bar chart with a dollar sign to represent value destruction.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
46
Uses a 'reason vs. reality' structure to undermine management's narrative.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
48
The slide uses a pie chart to visually suggest that non-core expenses (Executive/Director Compensation and G&A) represent a disproportionately large share of thexpose_contradiction
Open slide detailBeat · Agitate (Make it worse)
49
Uses a simple icon-grid to represent headcount growth.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
50
Uses comparative data to frame management's spending priorities as misaligned with shareholder interests.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
51
The slide uses a pill bottle icon to represent the commercialization focus.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
54
The MindMed bar is highlighted in red to emphasize its low ownership.compare_peers
Open slide detailBeat · Agitate (Make it worse)
55
The slide highlights Mind Medicine (MindMed) Inc. with a red highlight, suggesting it is the primary target of the activist campaign.compare_peers
Open slide detailBeat · Agitate (Make it worse)
56
Uses a table to contrast performance (price decline) with compensation metrics.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
57
Uses a checklist icon to visually represent the 'basic requirements' being criticized.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
58
Uses a sarcastic 'A+' graphic to emphasize the critique of management performance.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
59
Uses a causal-chain/logical-chain structure to show goal vs reality.expose_contradiction
Open slide detailBeat · Agitate (Make it worse)
61
MM-120 likely refers to a specific internal project or strategic initiative code.transition
Open slide detailBeat · Solution (Provide relief)
62
The table highlights the optimal dose range for future clinical trials.propose_solution
63
The diagram outlines a randomized clinical trial structure.present_framework
70
The slide uses a medical icon to emphasize the R&D nature of the spending.expose_contradiction
72
Includes open positions in current quantity; one projected role is noted as a consultant.analyze_data
Open slide detailBeat · Solution (Provide relief)
73
The chart uses dashed lines to indicate reporting relationships.plan_implementation
Open slide detailBeat · Solution (Provide relief)
75
The slide uses a microscope/test tube icon to represent R&D.propose_solution
Open slide detailBeat · Solution (Provide relief)
76
The slide uses a comparison frame to justify the proposed budget by showing a 27% reduction from FY2022 costs.propose_solution
Open slide detailBeat · Solution (Provide relief)
78
Includes a specific demand/proposal regarding capital allocation strategy.state_demand
Open slide detailBeat · Solution (Provide relief)
81
The slide shows a reduction in headcount across most G&A functions.analyze_data
Open slide detailBeat · Solution (Provide relief)
82
The slide highlights 'Administrative Expenses' and 'Miscellaneous Expenses' in blue, and shows a 66% savings calculation against FY2022 costs.analyze_data
Open slide detailBeat · Solution (Provide relief)
83
The slide includes a disclaimer at the bottom regarding the nature of the estimates.analyze_data
Open slide detailBeat · Solution (Provide relief)
84
Includes a disclaimer regarding the basis of estimates.transition
Open slide detailBeat · Solution (Provide relief)
85
The table uses a waterfall-style logic to arrive at the final cash balance.analyze_data
Open slide detailBeat · Solution (Provide relief)
87
The slide includes a specific commitment from the nominees to not sell shares until 2025 if elected.propose_solution
Open slide detailBeat · Solution (Provide relief)